HomeClinical TopicsFDA restricts patient access to rosiglitazone

FDA restricts patient access to rosiglitazone

The U.S. Food and Drug Administration (FDA) has added new restrictions on how rosiglitazone-containing medicines (Avandia, Avandamet, Avandaryl): Healthcare providers must enroll in a special program in order to prescribe the medicines, and patients must enroll in the same program in order to obtain their medicines through the mail. After November 18, 2011, rosiglitazone-containing medicines will no longer be available through retail pharmacies. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...